VEGFA and breast cancer: FZD5/NF-κB/ER signalling activated by the Wnt5a ligand targets FOSL2, a transcription factor of CAFs, promoting vascular endothelial growth factor (VEGF)-independent angiogenesis in breast cancer [70].